Odimma Therapeutics Revenue

Pharmaceutical Manufacturing • Illkirch-Graffenstaden, Grand Est, France • 1-10 Employees

Odimma Therapeutics revenue & valuation

Annual revenue	$2,700,000
Revenue per employee	$450,000
Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues	$8,700,000
Total funding	$2,000,000

Key Contact at Odimma Therapeutics

Pascale Balducchi

Ceo Odimma-Therapeutics

Company overview

Headquarters	1 rue Jean Sapidus Parc d'Innovation, ILLKIRCH GRAFFENSTADEN, Grandest 67400, FR
Website	odimma-therapeutics.com
NAICS	3254
Keywords	Personalized Medicine, Research & Development, Cancer Immunotherapy, Deeptech, Onco-Immunology
Founded	2017
Employees	1-10
Socials

Odimma Therapeutics Email Formats

Odimma Therapeutics uses 3 email formats. The most common is {first name}.{last name} (e.g., john.doe@odimma-therapeutics.com), used 50% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@odimma-therapeutics.com	50%
{first initial}.{last name}	j.doe@odimma-therapeutics.com	33.3%
{last name}	doe@odimma-therapeutics.com	16.7%

About Odimma Therapeutics

Odimma is a French biotech company with a unique approach in active personalized cancer immunotherapy. Immunotherapy has revolutionized the treatment of many advanced cancers. Despite this amazing achievement, significant clinical benefits are still limited to 10 to 30% of patients. Odimma believes in the future of precision medicine, and leverages recent advances in the field of immuno-oncology to amplify the efficacy of current therapies, improving lives and making each patient unique. By harnessing the ability of the patient’s own immune system to specifically recognize non-self-targets displayed by the tumor, also called neoantigens, Odimma has designed a next-generation personalized immunization platform that brings a sustainable therapeutic solution to fight the most hard-to-treat cancers. Carried by a team of experts and a supportive environment, we are now preparing our upcoming entry in the clinic

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Entry

Head

Employees by Department

Odimma Therapeutics has 5 employees across 4 departments.

Departments

Number of employees

Funding Data

Explore Odimma Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2023-05-13	3	$2,000,000

Funding Insights

$2,000,000

Total funding amount

$2,000,000

Most recent funding amount

Number of funding rounds

Odimma Therapeutics Tech Stack

Discover the technologies and tools that power Odimma Therapeutics's digital infrastructure, from frameworks to analytics platforms.

Apache HTTP Server

Web servers

jQuery

JavaScript libraries

PHP

Programming languages

Open Graph

Miscellaneous

OVHcloud

Hosting

Google Maps

Maps

Google Font API

Font scripts

Frequently asked questions

Odimma Therapeutics is located in Illkirch-Graffenstaden, Grand Est, FR.

Odimma Therapeutics generates an estimated annual revenue of $2,700,000. This revenue figure reflects the company's market position and business performance in its industry.

Odimma Therapeutics has an estimated valuation of $8,700,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Odimma Therapeutics was founded in 2017, making it 9 years old. The company has established itself as a significant player in its industry over this time.

Odimma Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Odimma Therapeutics has raised a total of $2,000,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contact at Odimma Therapeutics

Pascale Balducchi

Ceo Odimma-Therapeutics

4.8

40,000 users